glp 1 colitis GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Crohn's Disease Relevance of Glucagon-Like Peptide 1

This effect can be particularly beneficial in addressing conditions such as osteoporosis

In order to improve the medication compliance of diabetic patients, polylactic-co-glycolic acid (PLGA) was used to wrap exenatide drug, which has sustained-release effect, and the half-life is as long as 5-6 days

Aug 16 2021;11(8):e053019

N Engl J Med 375:18341844 Thompson AM, Trujillo JM (2015) Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes

Wouldnt use anything else

Manufacturing capacity constraints have exacerbated the situation, and as of mid-2024 still continue to affect Victoza and Ozempic production